New Wins in Combination Therapy for Lung Cancer
Cancer Lung Cancer Checkpoint Inhibitor

New Wins in Combination Therapy for Lung Cancer

Dr. Talia Henkle
Dr. Talia Henkle

In 10 seconds? Early-stage lung cancer patients who received both chemotherapy and checkpoint blockade inhibitor therapy before undergoing cancer removal surgery had better survival outcomes than those who received chemotherapy alone.

What’s the story? It seems that every single-agent cancer treatment trial recommends that combination therapy approaches (AKA combining multiple treatments) be tried next to improve treatment outcomes. But like everything in cancer, it’s not that simple. What agents should be combined and how? Finally, we’re starting to answer those questions for the cancer that kills the most people worldwide.

Get unlimited access to our 3-min Digests and other premium features

Choose your plan:

Sparrow Unlimited

$19/month
  • Includes a free 7-day trial
  • Weekly Recap email
  • Daily updates with the latest research
  • Unlimited access to all Digests
  • Explore all citations and resources
  • Review learnings with Quick Dive
  • The Sparrow Sessions Podcast
  • No advertisement
  • Cancel anytime

We'll send you a reminder email 3 days before your trial ends.

Start my free trial

Sparrow Unlimited

$99/year
  • Save 56% in one, easy payment
  • Includes a free 7-day trial
  • Weekly Recap email
  • Daily updates with the latest research
  • Unlimited access to all Digests
  • Explore all citations and resources
  • Review learnings with Quick Dive
  • The Sparrow Sessions Podcast
  • No advertisement
  • Cancel anytime

We'll send you a reminder email 3 days before your trial ends.

Start my free trial